Suchergebnisse - "Dvorkin, Mikhail"

PubPharm (12)

1

Durvalumab plus platinum-etoposide versus platinum-etoposide in first-line treatment of extensive-stage small-cell lung cancer (CASPIAN) : a randomised, controlled, open-label, phase 3 trial

enthalten in: Lancet (London, England) | 2019

von Paz-Ares, L. | Dvorkin, M. | Chen, Y. | +122

CommentIn: Lancet. 2019 Nov 23;394(10212):1884-1885. - PMID 31590987

2

Maintenance avelumab versus continuation of first-line chemotherapy in gastric cancer : JAVELIN Gastric 100 study design

enthalten in: Future oncology (London, England) | 2019

von Moehler, M. | Ryu, M. | Dvorkin, M. | +19

3

Trifluridine/tipiracil versus placebo in patients with heavily pretreated metastatic gastric cancer (TAGS) : a randomised, double-blind, placebo-controlled, phase 3 trial

enthalten in: The Lancet. Oncology | 2018

von Shitara, K. | Doi, T. | Dvorkin, M. | +18

CommentIn: Lancet Oncol. 2018 Nov;19(11):1418-1419. - PMID 30355454

4

Efficacy of Sym004 in Patients With Metastatic Colorectal Cancer With Acquired Resistance to Anti-EGFR Therapy and Molecularly Selected by Circulating Tumor DNA Analyses : A Phase 2 Randomized Clinical Trial

enthalten in: JAMA oncology | 2018

von Montagut, C. | Argilés, G. | Ciardiello, F. | +29

ErratumIn: JAMA Oncol. 2019 May 1;5(5):745. - PMID 31070664

5

Phase III, Randomized, Double-Blind Study Comparing the Efficacy, Safety, and Immunogenicity of SB3 (Trastuzumab Biosimilar) and Reference Trastuzumab in Patients Treated With Neoadjuvant Therapy for Human Epidermal Growth Factor Receptor 2-Positive Early Breast Cancer

enthalten in: Journal of clinical oncology : official journal of the American Society of Clinical Oncology | 2018

von Pivot, X. | Bondarenko, I. | Nowecki, Z. | +14

6

Fulvestrant 500 mg versus anastrozole 1 mg for hormone receptor-positive advanced breast cancer (FALCON) : an international, randomised, double-blind, phase 3 trial

enthalten in: Lancet (London, England) | 2016

von Robertson, J. | Bondarenko, I. | Trishkina, E. | +15

CommentIn: Lancet. 2017 Dec 17;388(10063):2961-2962. - PMID 27908455

7

Fulvestrant 500 mg versus anastrozole 1 mg for hormone receptor-positive advanced breast cancer (FALCON): an international, randomised, double-blind, phase 3 trial

enthalten in: The lancet | 2016

von Robertson, J. | Bondarenko, I. | Trishkina, E. | +15

8

De Novo Sequencing of Peptides from Top-Down Tandem Mass Spectra

enthalten in: Journal of proteome research | 2015

von Vyatkina, K. | Wu, S. | Dekker, L. | +8

9

De Novo Sequencing of Peptides from Top-Down Tandem Mass Spectra

enthalten in: Journal of proteome research | 2015

von Vyatkina, K. | Wu, S. | Dekker, L. | +8

10

De novo protein sequencing by combining top-down and bottom-up tandem mass spectra

enthalten in: Journal of proteome research | 2014

von Liu, X. | Dekker, L. | Wu, S. | +9